Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine as Adjuvant in Obturator Nerve Block for Transurethral Surgery
NCT06229054Phase 1Completed
- Sponsor
- Cairo University
- Start
- Feb 2024
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of dexmedetomidine in postoperative pain (2 arms), sponsored by Cairo University. Primary endpoint: Severity of pain measured by visual analog scale (VAS) score. Started Feb 2024; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06229054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06229054.